분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-07-27 17:21:15 , Hit : 1093
 Chinese Scientists To Test Gene Modifying Technique ‘CRISPR’ On Humans For The First Time

Science World Report

First Posted: Jul 23, 2016 05:30 AM EDT

It will be the first attempt ever that a group of Chinese scientists will inject genetically modified cells into human beings next month. The genes have been modified using the CRISPR-Cas9 gene-editing technique. The trial will begin from next month at the West China Hospital, Sichuan University.

Lead oncologist Lu You and his team will test gene-edited cells on lung cancer patients on whom treatments including chemotherapy and radiation therapy have already failed. What the team will do is they will extract immune cells known as T cells from the blood of the patients and use CRISPR-Cas9 to modify them. They will try to eliminate a gene from the cells that encodes a protein named PD-1, which normally keeps immune cells in check but is also used by cancer cells as a defensive mechanism.

The researchers are hoping that after they multiply the modified cells in the lab and re-introduce them into the patients' bloodstream, they will center the cancer and eliminate it. However, it is first to be made sure that the technique is safe, reported Digital Trends.

In the first trial, which begins in August, the research team will inject the CRISPR-edited cells in only one of the three patients in the group. After observing the patient if the team is satisfied by the results, they will perform the same treatment on the second patient. Future trials will depend on how effective the technique is compared to other types of treatment.

"This technique is of great promise in bringing benefits to patients, especially the cancer patients whom we treat every day," said Lu You, reported Daily Mail.

You said that the technology will have wide applications if it has good safety and shows certain efficacy. In fact, it has the potential to become an alternative biotechnology treatment to replace or complement the existing single-antibody drugs, he added, according to journal Nature.

This is for the first time that the CRISPR-Cas9 gene editing technique will be applied on human beings. Previously, Chinese scientists have tested the technique on human embryos and in monkeys and dogs.







987   미국 과학·공학·의학 아카데미, 「GM 베이비」의 진행방향에 대한 윤곽 발표  이성욱 2017/02/16 1071
986   Nano-CRISPR Packages Attain 90% Delivery Rate with Engineered Cas9  이성욱 2017/02/09 1327
985   유전자 치료로 청력 되살린다  이성욱 2017/02/08 1349
984   바이러스들도 서로 소통..“상황에 따라 감염방식 결정”  이성욱 2017/01/24 1133
983   Oligonucleotide Therapeutics Near Approval  이성욱 2017/01/10 1168
982   Off Switch Found for Common Version of the CRISPR-Cas9 System  이성욱 2017/01/02 994
981   Editas Expands CRISPR Capabilities through New Technology Licensing  이성욱 2016/12/22 819
980   RNA Modification Helps Drosophila Straighten Up and Fly Right  이성욱 2016/12/10 886
979   Anti-CRISPR Protein Is Gene Editing “Off-Switch”  이성욱 2016/12/10 1890
978   Could Gene Therapy Work for Alzheimer’s Disease?  이성욱 2016/10/12 1158
977   EU, 2번째 유전자치료제 ‘스트림벨리스’ 승인  이성욱 2016/09/05 1146
976   DNA Can Be Edited Without Being Cut  이성욱 2016/08/30 1418
975   Using RNA to Amplify RNA  이성욱 2016/08/16 1031
974   CRISPR: No Cutting Required  이성욱 2016/08/06 1636
973   “Kissing Disease” Virus Promotes Malignant Breast Cancer Development  이성욱 2016/08/03 1038
972   Lytic and latent viral replication prevented with CRISPR/Cas9  이성욱 2016/07/27 918
  Chinese Scientists To Test Gene Modifying Technique ‘CRISPR’ On Humans For The First Time  이성욱 2016/07/27 1093
970   FDA OKs AbbVie's once-daily Viekira XR for HCV-1  이성욱 2016/07/27 907
969   [미국] 유전자가위 규제 마련 지연과 기업들의 움직임  이성욱 2016/07/21 1102
968   5년새 20배 성장 `유전자치료제` 시장..경쟁력 확보 필수  이성욱 2016/07/21 986

[이전 10개] [1]..[11][12][13][14] 15 [16][17][18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN